TC BioPharm Receives MHRA and Research Ethics Committee Approvals to Initiate Phase 2B/3 Clinical Trials for the Treatment of Acute Myeloid Leukemia

/PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

Related Keywords

United Kingdom ,Edinburgh ,City Of ,Scotland ,Bryan Kobel ,Research Ethics Committee ,Tc Biopharm Ltd ,Research Ethics ,Tc Biopharm Holdings Plc ,Acute Myeloid Leukemia ,Orphan Drug Dsignation ,Tc Biopharm ,